AC Immune SA is a clinical-stage biopharmaceutical company, which engages in the discovery and development of therapeutic and diagnostic products for neurodegenerative diseases. It leverages proprietary technology platforms to discover, design, and develop novel, proprietary medicines for prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The company was founded by Jean-Marie Lehn, Claude Nicolau, Roscoe Brady, Fred van Leuven, Ruth Greferath, Andrea Pfeifer, and Alexey V. Eleesiv on February 13, 2003 and is headquartered in Lausanne, Switzerland.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
172
Frequently Asked Questions
What is Market Cap of AC Immune SA?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. AC Immune SA market cap is $225.59M.
What is the 52-week high for AC Immune SA?
52 week high is the highest price of a stock in the past 52 weeks, or one year. AC Immune SA 52 week high is $3.98 as of September 07, 2025.
What is the 52-week low for AC Immune SA?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. AC Immune SA 52 week low is $1.43 as of September 07, 2025.
What is AC Immune SA stock price today?
AC Immune SA stock price today is $2.28.
What was AC Immune SA stock price yesterday?
AC Immune SA stock price yesterday was $2.15.
What is the PE ratio of AC Immune SA?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. AC Immune SA’s P/E ratio is -3.92.
What is the Price-to-Book ratio of AC Immune SA?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. AC Immune SA P/B ratio is 2.1378.
What is the 50-day moving average of AC Immune SA?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. AC Immune SA 50-day moving average is $2.14.
